Human Papillomavirus Types 52 and 58 Are Prevalent in Uterine Cervical Squamous Lesions from Japanese Women

Table 3

Prevalence of HPV and cytological findings by age.

(a) Women without cytological abnormalities (NILM)

HPV type	10–19; 𝑛=22	20–29; 𝑛=331	30–39; 𝑛=461	40–49; 𝑛=537	50–59; 𝑛=403	60–69; 𝑛=197	>70; 𝑛=117	All; 𝑛=2068
HPV 16	1 (4.5%)	7 (2.1%)	12 (2.6%)	8 (1.5%)	1 (0.2%)	0	1 (0.9%)	30 (1.5%)
HPV 18	1 (4.5%)	8 (2.4%)	6 (1.3%)	4 (0.7%)	1 (0.2%)	1 (0.5%)	0	21 (1.0%)
HPV 52	1 (4.5%)	15 (4.5%)	7 (1.5%)	8 (1.5%)	5 (1.3%)	7 (3.6%)	3 (2.6%)	46 (2.2%)
HPV 58	1 (4.5%)	10 (3.0%)	15 (3.3%)	4 (0.7%)	0	2 (1.0%)	1 (0.9%)	33 (1.6%)

(b) Women with cytological abnormalities

HPV type	10–19; 𝑛=21	20–29; 𝑛=271	30–39; 𝑛=358	40–49; 𝑛=290	50–59; 𝑛=153	60–69; 𝑛=69	>70; 𝑛=33	All; 𝑛=1195
HPV 16	3 (14.0%)	88 (32.5%)	69 (19.3%)	46 (15.9%)	15 (9.8%)	7 (10.1%)	3 (9.1%)	231 (19.3%)
HPV 18	3 (14.0%)	18 (6.6%)	15 (4.2%)	8 (2.8%)	6 (3.9%)	2 (2.9%)	0	52 (4.4%)
HPV 52	5 (23.8%)	62 (22.9%)	70 (19.6%)	48 (16.6%)	19 (12.4%)	20 (29.0%)	6 (18.2%)	230 (19.2%)
HPV 58	3 (14.0%)	56 (20.7%)	58 (16.2%)	37 (12.8%)	16 (10.5%)	20 (29.0%)	3 (9.1%)	193 (16.2%)

(c) Women with cytological abnormalities of HSIL or more

HPV type	10–19; 𝑛=4	20–29; 𝑛=127	30–39; 𝑛=183	40–49; 𝑛=117	50–59; 𝑛=64	60–69; 𝑛=41	>70; 𝑛=18	All; 𝑛=554
HPV 16	1 (25.0%)	59 (46.5%)	53 (29.0%)	36 (30.8%)	14 (21.9%)	4 (9.8%)	3 (16.7%)	170 (30.7%)
HPV 18	0	5 (3.9%)	10 (5.5%)	6 (5.1%)	5 (7.8%)	2 (4.9%)	0	28 (5.1%)
HPV 52	1 (25.0%)	29 (22.8%)	42 (23.0%)	28 (23.9%)	12 (18.8%)	13 (31.7%)	6 (33.3%)	131 (23.6%)
HPV 58	1 (25.0%)	31 (24.4%)	35 (19.1%)	17 (14.5%)	11 (17.2%)	12 (29.3%)	2 (11.1%)	109 (19.7%)